Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 6/20 | 0.40 |
| ▸ | ALOX15 | P16050 | 4/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 4/20 | 0.39 |
| ▸ | HTT | P42858 | 2/20 | 0.39 |
| ▸ | USP2 | O75604 | 3/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.37 |
| ▸ | MAPT | P10636 | 2/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
| ▸ | DPP4 | P27487 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9708380 | 0.94 | TSHR (0.40) | TSHRALOX15HSD17B10ALDH1A1NPSR1 | |
| SCHEMBL9707869 | 0.94 | AGTR1 (0.36) | — | |
| SCHEMBL9707526 | 0.92 | ADORA3 (0.37) | — | |
| SCHEMBL9707493 | 0.92 | — | — | |
| SCHEMBL9708264 | 0.92 | TSHR (0.42) | TSHRALOX15HSD17B10ALDH1A1NPSR1 | |
| SCHEMBL9707970 | 0.91 | ADORA3 (0.36) | — | |
| SCHEMBL9708621 | 0.91 | AGTR1 (0.35) | ALDH1A1 | |
| SCHEMBL9708619 | 0.91 | ALOX15 (0.39) | TSHRALOX15HSD17B10ALDH1A1NPSR1 | |
| SCHEMBL9708248 | 0.91 | AGTR1 (0.36) | — | |
| SCHEMBL9707574 | 0.90 | AGTR1 (0.42) | TSHRALOX15HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-1992007852-A1 | BIPHENYLALKYL XANTHINE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS | G.D. SEARLE & CO. (US) | 1992-05-14 | — | — | WO | disclosed |